Apellis Pharmaceuticals, Inc. (APLS)

Last Closing Price: 24.85 (2025-09-12)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Apellis Pharmaceuticals, Inc. (APLS) had Weighted-Average Shares Outstanding (Diluted) of 123.91M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$781.37M
$-197.88M
$117.72M
$663.64M
$946.35M
$-164.98M
$-31.74M
$-196.72M
$-196.72M
$-197.88M
$-197.88M
$-197.88M
$-197.88M
$-164.98M
$-152.69M
123.91M
Weighted-Average Shares Outstanding (Diluted)
123.91M
$-1.60
$-1.60
Balance Sheet Financials
$788.95M
$2.95M
$96.10M
$885.05M
$185.51M
$452.83M
$471.00M
$656.51M
$228.54M
$228.54M
$228.54M
124.50M
Cash Flow Statement Financials
$-87.87M
$-0.40M
$149.24M
$352.30M
$412.61M
$60.31M
$114.13M
--
--
Fundamental Metrics & Ratios
4.25
--
--
0.66
1.98
84.93%
-21.11%
-21.11%
-19.54%
-25.18%
-25.32%
$-88.27M
--
--
--
0.88
1.45
2.95
123.75
-86.58%
-86.58%
-22.36%
-29.04%
$1.84
$-0.71
$-0.71